Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-552-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Water solubility
Administrative data
Link to relevant study record(s)
- Endpoint:
- water solubility
- Type of information:
- other: Scientific statement from Novo Nordisk A/S
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
Data on target substance is sparse. However, the data provided is supported by read-across from source substances (S3 and S4).
The target substance liraglutide precursor is a single-chain polypeptide consisting of 31 amino acids having an almost identical amino acid sequence as the human glucagon-like peptide 1 (GLP-1) that has 30 amino acids of which 29 amino acids in common with the target substance.
The target substance is a part of the active pharmaceutical ingredient: liraglutide (S1) as the liraglutide molecule has been obtained from the liraglutide precusor be the addition of a plamitoyl-ϒ-glutamate unit attached to the amino acid lysine in position 26 of the precusor.
S3 and S4 substances are somewhat larger polypeptides as consisting of 53 and 50 amino acids in the polypeptide chain.
Each of the amino acids in the above mentioned substances are and very polar molecules and when linked together in polypeptides the very polar nature of the polypeptides are considered as having very similar physicochemical properties irrespective whether they contain 31 (T) or 50 amino acids (S3,S4) for which physicochemical properties have been obtained. Thus, the results from physicochemical guideline testing for S3 and S4 for melting point, boiling point, flammability, self-ignition, and explosionwere identical and can be considered as representative for the target substance as well. With respect to vapour pressure the vapour pressure for single amino acids is extremely low (below 0.4 Pa) and thus, the vapour pressure for polypeptides would be expected to be even lower.
Data matrix for S1, S2, S3 and T is provided in section 13.- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- other: Scientific statement by Novo Nordisk A/S
- Key result
- Water solubility:
- > 60 g/L
- Remarks on result:
- other: as disolved in pure water
- Key result
- pH:
- 4.5 - 6.5
- Remarks on result:
- not determinable
- Remarks:
- insoluble
- Details on results:
- The water solubility as indicated in the table has been provided by Novo Nordisk (2015 + 2017)
- Conclusions:
- In the interval of pH 4.5-6.5 the substance can be considered as insoluble.
In pure water the solubility is above 60 g/L - Executive summary:
As the general experience with the substanse the following company data has been obtained:
In the interval of pH 4.5-6.5 the substance can be considered as insoluble.
In pure water the solubility is above 60 g/L
Such a solubility profile can be supported by read-across from the source substances
MI3 (S3) and X14DesB30 (S(4).
S3 and S4 substances are somewhat larger polypeptides as consisting of 53 and 50 amino acids in the polypeptide chain.
Each of the amino acids in the above mentioned substances are and very polar molecules and when linked together in polypeptides the very polar nature of the polypeptides are considered as having very similar physicochemical properties irrespective whether they contain 31 (T) or 50 amino acids (S3,S4) for which physicochemical properties have been obtained.
The water solubility of MI3 and X14DesB30 (solution) were determined by the shake flask method. The procedure conformed to EC Directive 92/69/EEC Method A6, and OECD Guideline 105 (1995). The solubility of MI3 at 20oC in double distilled water was determined to be 393.1 mg/L±44.0 mg/L with a resultant pH of nominally 7.9. The solubility of X14DesB30 at 20oC in double distilled water was determined to be 43 g/L at pH 3.6. However, Human insulin is insoluble in the pH range of 4.5 – 6.5, but outside this it has a solubility >10g/L. Therefore, read-across from these substances provides support to the company data indicating:
In the interval of pH 4.5-6.5 Liraglutide precursor can be considered as insoluble.
In pure water the solubility is above 60 g/L
- Endpoint:
- water solubility
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000.03.16 – 2000.09.18
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 105 (Water Solubility)
- Deviations:
- yes
- Remarks:
- Deviation in the incubation temperature measured to be 18.6 oC instead of 19.5 to 20.5 oC as specified by the guideline. This deviation is considered to have little impact on the test results.
- Qualifier:
- according to guideline
- Guideline:
- EU Method A.6 (Water Solubility)
- Deviations:
- yes
- Remarks:
- Deviation in the incubation temperature measured to be 18.6 oC instead of 19.5 to 20.5 oC as specified by the guideline. This deviation is considered to have little impact on the test results.
- GLP compliance:
- yes (incl. QA statement)
- Type of method:
- flask method
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL (MI3 solution)
- Appearance: brown paste
- Source and lot/batch No.of test material: QC202426
- Expiration date of the lot/batch: June 2004
- Purity test date: 2003-06-18
- Purity: 84% w/w (stated ny Sponsor)
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Frozen below - 10°C - Key result
- Water solubility:
- ca. 393 mg/L
- Conc. based on:
- test mat. (dissolved fraction)
- Incubation duration:
- ca. 24 - ca. 72 h
- Temp.:
- 30 °C
- pH:
- ca. 7.8 - ca. 8.06
- Remarks on result:
- other: Standard deviation of +/- 44 mg/mL
- Conclusions:
- The water solubility of MI3 (solution) was determined by the shake flask method. The procedure conformed to EC Directive 92/69/EEC Method A6, and OECD Guideline 105 (1995). The solubility of MI3 at 20 oC in double distilled water was determined to be 393.1 mg/L ± 44.0 mg/L with a resultant pH of nominally 7.9.
- Executive summary:
The water solubility of MI3 (solution) was determined by the shake flask method. The procedure conformed to EC Directive 92/69/EEC Method A6, and OECD Guideline 105 (1995). The solubility of MI3 at 20oC in double distilled water was determined to be 393.1 mg/L±44.0 mg/L with a resultant pH of nominally 7.9. This is equivalent to a CV of 11.2%, which is within the recommended limit (±15 %), and therefore considered acceptable especially when keeping in mind that the incubation bath temperature of 18.6oC, was outside the specified temperature of 20oC±0.5oC.
- Endpoint:
- water solubility
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000.03.10 - 2000.09.21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 105 (Water Solubility)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method A.6 (Water Solubility)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of method:
- other: miscibility test
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL (X14desB30)
- Appearance: Brown solid when frozen, brown paste when thawed.
- Source and lot/batch No.of test material: X14ISO201014
- Expiration date of the lot/batch: NA
- Purity test date: 2000-02-18
- Purity: 155 mg/g Active Ingredient (stated by sponsor)
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Stored < - 10 degree celcius. - Key result
- Water solubility:
- ca. 43 - ca. 56.17 g/L
- Conc. based on:
- test mat. (total fraction)
- Temp.:
- 20 °C
- pH:
- ca. 3.6
- Conclusions:
- Determination of the water solubility of X14desB30 was performed using a miscibility test in accordance to OECD guideline 105 (1995). The solubility of X14DesB30 at 20oC in double distilled water was evaluated to be 43 g/L at pH 3.6.
- Executive summary:
Determination of the water solubility of X14desB30 was performed in accordance to OECD guideline 105 (1995) and EC Directive 92/69/EEC Methods A6. The test substance was inhomogeneous in suspension in water, hence the flask method and column elution method was not applicable and a miscibility test was performed. The solubility of X14DesB30 at 20oC in double distilled water was evaluated to be 43 g/L at pH 3.6.
Referenceopen allclose all
Calibration data is presented in the table below; the calibartion line was established linearly with 1/x weighting.
Sequence reference |
WSOL2 |
Slope |
46441.6 |
Intercept |
-10980.08 |
Correlation |
0.99983 |
Minimum calibrant conc (µg/ml) |
0.5 |
Maximum calibrant conc (µg/ml) |
50 |
Analytical data is shown in the table below. The incubation bath was constant at a temperature of 18.6oC over the test period.
Test ref |
Time at 30oC (h) |
pH |
Dilution factor |
Peak area |
MI3 conc (mg/L) |
1 |
72 |
7.80 |
100 |
139980.1 |
325.05 |
2 |
72 |
7.94 |
100 |
204180.4 |
463.29 |
3 |
48 |
7.97 |
100 |
174576.7 |
399.55 |
4 |
48 |
7.97 |
100 |
168503.7 |
386.47 |
5 |
24 |
8.06 |
100 |
169386.6 |
388.37 |
6 |
24 |
8.02 |
100 |
172798.3 |
395.72 |
Description of key information
As the general experience with the substanse the following company data has been optained:
In the interval of pH 4.5-6.5 the substance can be considered as insoluble.
In pure water the solubility is above 60 g/L
Such a solubility profile can be supported by read-across from the source substances
MI3 (S3) and X14DesB30 (S(4).
S3 and S4 substances are somewhat larger polypeptides as consisting of 53 and 50 amino acids in the polypeptide chain.
Each of the amino acids in the above mentioned substances are and very polar molecules and when linked together in polypeptides the very polar nature of the polypeptides are considered as having very similar physicochemical properties irrespective whether they contain 31 (T) or 50 amino acids (S3,S4) for which physicochemical properties have been obtained.
The water solubility of MI3 and X14DesB30 (solution) were determined by the shake flask method. The procedure conformed to EC Directive 92/69/EEC Method A6, and OECD Guideline 105 (1995). The solubility of MI3 at 20oC in double distilled water was determined to be 393.1 mg/L±44.0 mg/L with a resultant pH of nominally 7.9. The solubility of X14DesB30 at 20oC in double distilled water was determined to be 43 g/L at pH 3.6. However, Human insulin is insoluble in the pH range of 4.5 – 6.5, but outside this it has a solubility >10g/L. Therefore, read-across from these substances provides support to the company data indicating:
In the interval of pH 4.5-6.5 Liraglutide precursor can be considered as insoluble.
In pure water the solubility is above 60 g/L.
Key value for chemical safety assessment
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.